AccessPak for HIV PEP Expanded with Viracept and Jivi Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Jivi Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: Jivi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Jolessa
- AccessPak for HIV PEP Expanded with Viracept-Jolessa extended-cycle
- AccessPak for HIV PEP Expanded with Viracept-Jolivette
- AccessPak for HIV PEP Expanded with Viracept-Jornay PM
- AccessPak for HIV PEP Expanded with Viracept-Juleber
- AccessPak for HIV PEP Expanded with Viracept-Juluca
- Jivi Intravenous-Accolate
- Jivi Intravenous-Accretropin
- Jivi Intravenous-Accucaine
- Jivi Intravenous-AccuHist Drops
- Jivi Intravenous-AccuHist PDX Drops
- Jivi Intravenous-AccuHist PDX Syrup